Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
about
Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased MortalityAtrial fibrillation in heart failure: what should we do?Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataDigoxin-associated mortality: a systematic review and meta-analysis of the literature2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.A Review of the Key Clinical Trials of 2015: Results and ImplicationsOuabain-digoxin antagonism in rat arteries and neuronesManagement Of Atrial Fibrillation In Patients With Heart Failure2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study.Quality of care in patients with atrial fibrillation in primary care: a cross-sectional study comparing clinical and claims data.Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF studyDigoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortLaquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.Digoxin: A systematic review in atrial fibrillation, congestive heart failure and post myocardial infarctionAtrial fibrillation in heart failure: The sword of Damocles revisited.Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF survey.Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis.The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile.Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 TrialIs foxglove effective in heart failure?Digoxin: its role in contemporary medicine.Comorbidity of atrial fibrillation and heart failure.Role of Digoxin in Atrial Fibrillation.Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative.Contemporary Controversies in Digoxin Use in Systolic Heart Failure.Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure.Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.High rate of mortality in Spanish community-dwelling population aged 85 with atrial fibrillation after three years of follow-up: The Octabaix study.Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail?Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality.Opposing conclusions from post hoc analyses of the AFFIRM trial: was propensity score analysis to blame or just an innocent victim?Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy.[Therapeutic management of non-valvular atrial fibrillation. Update 2013].Atrial fibrillation in the elderly: a review.Arrhythmias: drugs and devices.
P2860
Q26770768-9A36CBD3-0799-4BA8-B52A-26F0DF84BE30Q26784426-F9F50533-28B6-4DFA-8FC3-06F17E6E8A21Q26796271-BCEBDFC1-21CE-423D-A3DE-4904E59DFD17Q27026975-BDB0326E-C4D0-4E54-9F95-2D3BDE30F0B9Q27341873-D14E6E19-C5C2-4627-B102-C96F2568AFFCQ28077170-9FEE4792-52A9-44E5-8170-662C6293C2C4Q28304163-AAF22E63-39DF-4A12-885A-9FEF3F94EA83Q30354835-CA2D2AF4-674D-40CC-B7D3-244DB1A927F4Q30653045-78E5B296-74CD-456B-9BD2-CC05EAD37C57Q31133255-469DAD26-08AF-450A-8D17-CC52885E3E0FQ31149219-E6FE66FA-0949-4D04-9B1F-67EDE30021D9Q35102218-9C9DA269-1C4E-4F71-8DFC-770AFA6F2B8CQ35511302-D3928DB5-3293-4013-815D-FAE14F0701CFQ35789263-E0B326B8-AB5E-46A9-AAC5-FB1E1D2CB1C7Q36136472-4D08940A-72CC-4C66-9065-AA593E7B563CQ36321059-970825CB-E970-4DA1-8817-55BD0B605AD4Q37043226-1171F98D-AD58-41DC-B688-5094D4E29657Q37538004-E81F9E66-2EBE-4B80-8FA5-8D3DDFEB9794Q37599290-B4242724-7F3B-46DE-AAEB-3CD0103E04C8Q37624266-96026D97-6BD2-4163-A1AF-886E3E963849Q37684261-04871B2A-B0AD-4A7E-84C7-4E9EC6092DC4Q38127568-50732E48-262D-4718-9054-98DC741F22CBQ38191517-F5818B5F-ACD9-4ADF-9826-3A5C1BF8388EQ38374710-1F24F10F-DBE0-4E5F-8DB1-AF512B703676Q38449921-3747E9B3-DCB2-4196-86E8-86E95A7EFAF2Q38565140-11DF967D-F821-4ED8-B14A-D9F1672145C8Q38666884-B7B322C2-0F6A-46FF-9B77-7BCDB6D96CE3Q38805268-C15B9AB1-3E32-4B89-A039-E8D266D08D4CQ38813385-0679CD1F-CCAB-427A-8D99-ED575C2E11D5Q38970521-783500C9-3917-4EFF-B85B-754C0DA15E2AQ39075410-5B7CB22C-4FF5-4A0E-94B5-97EF643694A6Q39199508-C550EF52-66BB-4BAD-8E8F-1C3540260442Q39909186-D1C0A411-0669-47A0-A6DA-E4115A5E661FQ41341553-12748A64-FB67-4D87-B9F2-BA6E3DA0470BQ42673198-D851DB14-1121-4B76-980A-854F1CA111CCQ42748645-C010CDF5-7D33-4CDD-8F99-EE5AA4B0D786Q43596338-6CED6518-3B69-4E62-9940-7DB4CEBF0562Q44676772-A9A019E3-17C5-4474-B784-737EE7D9B528Q51026059-5D48BA13-8F59-4093-A22A-731363788AA0Q51838722-B10B2DFB-AD14-4E35-B941-B0CDAC72333A
P2860
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lack of evidence of increased ...... analysis of the AFFIRM trial.
@en
type
label
Lack of evidence of increased ...... analysis of the AFFIRM trial.
@en
prefLabel
Lack of evidence of increased ...... analysis of the AFFIRM trial.
@en
P2093
P2860
P50
P356
P1476
Lack of evidence of increased ...... analysis of the AFFIRM trial.
@en
P2093
Andrew E Epstein
Inmaculada B Aban
John G F Cleland
Kanan Patel
Wilbert S Aronow
P2860
P304
P356
10.1093/EURHEARTJ/EHT120
P577
2013-04-16T00:00:00Z